Essential Partners’s Bio-Techne TECH Stock Holding History

Essential Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14	Closed	-$732	–	2956
2026 Q1	$732	Buy	+14	New	+$840	﹤0.01%	2325

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Essential Partners's TECH Position: Q2 2026 in Review

Essential Partners sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 14 shares — an estimated $732 sold.

Essential Partners first reported a position in TECH in Q1 2026 and held it in 1 quarter. The position peaked at $732 in Q1 2026. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Essential Partners reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
Essential Partners sold 14 Bio-Techne shares in Q2 2026, an estimated $732.
Essential Partners first reported a position in Bio-Techne in Q1 2026 and held it in 1 quarter.
Essential Partners's Bio-Techne position peaked at $732 in Q1 2026.
597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.